Intracoronary transplantation of labelled mesenchymal stem cells post myocardial infarction is associated with increased angiogenesis but fails to enhance functional recovery
CL Dubois, Stefan Janssens(Maastricht University), Hilde Gillijns(Ghent University), Glenn Marsboom(Johnson & Johnson (United States)), Frans Van de Werf(KU Leuven), Désiré Collen(Ghent University), Péter Pokreisz(Ghent University), Peter Jans, Witold Streb
Journal of the American College of Cardiology
February 1, 2005
Cited by 1
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
|Nature|1996|4.2k
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
|New England Journal of Medicine|2003|2.5k
Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
|New England Journal of Medicine|2013|1.5k